Pharmena Company Description

Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally.

It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications.

Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.

Pharmena S.A.

Country	Poland
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	7
CEO	Konrad Palka

Contact Details

Address: Gdanska 47/49 Lódz, 90-729 Poland
Phone	48 42 280 77 07
Website	pharmena.eu

Stock Details

Ticker Symbol	PHR
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
ISIN Number	PLPHRMN00011
SIC Code	2834

Key Executives

Name	Position
Konrad Palka	President of Management Board, Chief Executive Officer and President
Marzena Wieczorkowska	Vice President of the Management Board and VP of Research and Development